ATRA
#3972
Atara Biotherapeutics, Inc. - Common Stock
9.2 0 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.54%
Monthly Change
+12.47%
6 month change
+76.58%
Year Change
-37.63%
Previous Close
9.2 5
Open
9.2 0
Low
9.2 0
High
9.2 0
Volume
3
Financials
- Market Capitalization 92.35 M
- Employee 10
- Founded 2012
- CEO N/A
- Website www.atarabio.com
- Headquarter Delaware, United States
- FIGI BBG005Q3MQY4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
7.04
Price to sales ratio
1.9
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3950 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.03 USD | -1.71% | -2.42% | +33.00% | -60.61% | 95.93 M USD | ||
| 3971 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.77 USD | -1.07% | -2.12% | -17.56% | +1.84% | 92.38 M USD | ||
| 3973 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.07 USD | -0.98% | -0.98% | +22.76% | +49.56% | 92.29 M USD | ||
| 3978 |  ICCC ImmuCell Corporation - Common Stock | 9.94 USD | -0.80% | -1.19% | -9.72% | +58.03% | 90.28 M USD |
Frequently asked questions about Atara Biotherapeutics, Inc
What is the Atara Biotherapeutics, Inc stock price today?
The current price of Atara Biotherapeutics, Inc (ATRA) is 9.20. Over the past 24 hours, the stock has changed by -0.54%. Follow the ATRA chart for real-time price dynamics.
What is the stock ticker of Atara Biotherapeutics, Inc?
Atara Biotherapeutics, Inc trades under the ticker ATRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Atara Biotherapeutics, Inc stock going up?
ATRA has changed by -3.87% over the last week, +12.47% over the last month, and -37.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Atara Biotherapeutics, Inc?
Atara Biotherapeutics, Inc currently has a market capitalization of 92.35 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Atara Biotherapeutics, Inc earnings last quarter?
Last quarter, Atara Biotherapeutics, Inc reported earnings of -0.32 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Atara Biotherapeutics, Inc revenue for the last quarter?
Atara Biotherapeutics, Inc reported quarterly revenue of 630 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Atara Biotherapeutics, Inc net income for the last quarter?
Atara Biotherapeutics, Inc reported net income of -4.83 M for the last quarter. The previous quarter showed -4.14 M, which means net income changed by -16.62%.
How many employees does Atara Biotherapeutics, Inc have?
As of the latest available data, Atara Biotherapeutics, Inc has 10 employees. Workforce size can provide additional context about the company's scale and operations.
What is Atara Biotherapeutics, Inc EBITDA?
Atara Biotherapeutics, Inc EBITDA is -4.7 M, and its EBITDA margin is -746.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Atara Biotherapeutics, Inc stock?
You can buy Atara Biotherapeutics, Inc (ATRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Atara Biotherapeutics, Inc stock?
Investing in Atara Biotherapeutics, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ATRA chart and related analysis on metatrader.com as part of your research.